| Literature DB >> 19914838 |
Karine Descroix1, Vaclav Vetvicka, Isabelle Laurent, Frank Jamois, Jean-Claude Yvin, Vincent Ferrières.
Abstract
Oligo-beta-(1,3)-glucans were chemically modified in order to introduce a structural variation specifically on the reducing end of the oligomers. The impact of well defined structural modulations was further studied on cancer cells and murin models to evaluate their cytotoxicity and immunostimulating potential. Copyright (c) 2009 Elsevier Ltd. All rights reserved.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19914838 DOI: 10.1016/j.bmc.2009.10.053
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641